Friday, June 12, 2015

MERS: Korea Reports 11th Fatality, WHO To Convene IHR Emergency Committee

# 10,193

Although the number of new Korean MERS cases dropped to 4 in the last report, this morning the Korean CDC has announced the 11th fatality of this outbreak; case # 51 previously described as Female, 72, onset June 2, who occupied the same ward as the outbreak's index case.

Homers confirmed Now add one people died, deaths 11th 
51st letter confirmed the initial diagnosis-party contact during inpatient treatment at St. Mary's Hospital in Pyeongtaek 
Department of Health and Human Services' central Homers management task force "is Fri June 12th, Homers confirmed deaths announced additional one (11th deaths) during parties. 
Admitted to St. Mary's Hospital in Pyeongtaek deaths among 51 confirmed one party (over 72 years) to 5.12 to 5.21 days, it was in contact with the first confirmed characters, from 6.5 days at Chonbuk National University Hospital isolation ward of the hospital treatment was diagnosed decision, state 6.12 days to deteriorate and died AM (11:50). 
* The pneumonia is aggravated due to old age, and acute renal failure occurs, died of multiple organ dysfunction syndrome

Meanwhile media sources are reporting that the WHO will convene a new meeting of the IHR Emergency Committee next week to consider whether the  MERS Coronavirus constitutes a PHEIC (Public Health Emergency of International Concern).

The last such meeting (#8) was held in February, when the committee decided the threat - while serious - did not rise to that level.  While I've not seen an official announcement from the WHO, today's WER (Weekly Epidemiological Record) from the WHO indicates the committee has been, or will be, convened.

Follow the link to read the entire MERS review.

Weekly Epidemiological Record (WER), 12 June 2015, vol. 90, 24 (pp. 297–308) [EN/FR]
          Fact sheet on Middle East respiratory syndrome       Coronavirus (June 2015)

WHO is working with clinicians and scientists in affected countries and internationally to gather and share scientific evidence to better understand the virus and the disease it causes, and to determine outbreak  response priorities, treatment strategies, and clinical management approaches. The Organization is also working with countries to develop public health prevention strategies to combat the virus.
Together with affected countries and international technical partners and networks, WHO is coordinating the global health response to MERS, including: the provision of updated information on the situation; conducting risk assessments and joint investigations with national authorities; convening scientific meetings; and developing guidance and training for health authorities and technical health agencies on interim surveillance  recommendations, laboratory testing of cases, infection prevention and control, and clinical management.

The Director-General has convened an Emergency  Committee under the International Health Regulations (2005) to advise her as to whether this event constitutes a Public Health Emergency of International Concern (PHEIC) and on the public health measures that should be taken. The Committee has met a number of times since the disease was first identified. WHO encourages all Member States to enhance their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns of SARI or pneumonia cases. 

Countries, whether or not MERS cases have been reported in them, should maintain a high level of vigilance, especially those with large numbers of travellers or migrant workers returning from the Middle East. Surveillance should continue to be enhanced in these countries according to WHO guidelines, along with infection prevention and control procedures in healthcare facilities.   
WHO continues to request that Member States report to WHO all confirmed and probable cases of infection with MERS-CoV together with information about their exposure, testing, and clinical course to inform the most effective international preparedness and response.

No comments: